{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:16:48Z","timestamp":1789143408335,"version":"build-2803163510"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","license":[{"start":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T00:00:00Z","timestamp":1735257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,27]]},"abstract":"<jats:p>\n                    The objective of this study was to investigate the potential causal relationship between coagulation factors and autoimmune diseases (ADs). We employed Mendelian randomization to investigate the associations between selected 7 coagulation factors and 10 ADs, leveraging genetic variants as instrumental variables to assess causal relationships between exposures of interest and outcomes. Within the scope of this investigation, coagulation factors were designated as the exposure source, while ADs were observed to manifest as the consequent outcome. Our analysis using the inverse-variance weighted (IVW) method revealed that Factor VIII (FVIII) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0067) exhibited significant causal associations with a reduced risk of multiple sclerosis. In contrast, fibrinogen (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0004) was associated with an increased risk of multiple sclerosis. The analysis also indicated that activated partial thromboplastin time (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0047) was implicated in elevating the risk of urticaria. The results also showed that protein C (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0188) was inversely associated with the risk of systemic lupus erythematosus. The results unveiled a significant positive correlation between fibrinogen (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0318) and the risk of rheumatoid arthritis. Similarly, Factor VII (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0119), FVIII (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0141), and von Willebrand Factor (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0494) were also found to be positively associated with the risk of inflammatory bowel disease. The IVW analysis demonstrated a causal relationship between von Willebrand Factor (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0316) and FVIII (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0408) and a decreased risk of primary sclerosing cholangitis. IVW results confirmed that protein C (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.0409) had a protective effect on vitiligo. No significant associations were found between psoriatic arthritis, rosacea, and the 7 coagulation factors in this study. This is of significant importance for advancing the prevention, diagnosis, and treatment of ADs.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000040893","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T21:01:37Z","timestamp":1735592497000},"page":"e40893","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The effects of coagulation factors on the risk of autoimmune diseases: A Mendelian randomization study"],"prefix":"10.1097","volume":"103","author":[{"given":"Shuxuan","family":"Li","sequence":"first","affiliation":[{"name":"Clinical Laboratory, Tianjin First Center Hospital, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Tianjin First Center Hospital, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Tianjin First Center Hospital, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Kang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Tianjin First Center Hospital, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2684-4979","authenticated-orcid":false,"given":"Hong","family":"Mu","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Tianjin First Center Hospital, Tianjin, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases.","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"102709","DOI":"10.1016\/j.autrev.2020.102709","article-title":"The roles of adenosine deaminase in autoimmune diseases.","volume":"20","author":"Gao","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2015.33","article-title":"Autoimmune diseases: Connecting risk alleles with molecular traits of the immune system.","volume":"17","author":"Gutierrez-Arcelus","year":"2016","journal-title":"Nat Rev Genet"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"102861","DOI":"10.1016\/j.jaut.2022.102861","article-title":"Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target.","volume":"132","author":"Lou","year":"2022","journal-title":"J Autoimmun"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease.","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2013-204767","article-title":"Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system.","volume":"73","author":"Van Den Oever","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1538-7836.2003.00261.x","article-title":"Inflammation and thrombosis.","volume":"1","author":"Esmon","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.maturitas.2008.11.008","article-title":"Reprint of crosstalk between inflammation and thrombosis.","volume":"61","author":"Esmon","year":"2008","journal-title":"Maturitas"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00296-016-3630-0","article-title":"The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study.","volume":"37","author":"Liang","year":"2017","journal-title":"Rheumatol Int"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/1535370216681549","article-title":"Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.","volume":"242","author":"Pretorius","year":"2017","journal-title":"Exp Biol Med"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"106979","DOI":"10.1016\/j.intimp.2020.106979","article-title":"Activated coagulation is associated with the disease activity of axial spondyloarthritis.","volume":"88","author":"Li","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1055\/s-0035-1556590","article-title":"Hypercoagulability and platelet abnormalities in inflammatory bowel disease.","volume":"41","author":"Senchenkova","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"R13-20260911","first-page":"833","article-title":"Inflammation and coagulation.","volume":"4","author":"Levi","year":"2017","journal-title":"Inflammation"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/ndt\/gfq098","article-title":"Mendelian randomization: use of genetics to enable causal inference in observational studies.","volume":"25","author":"Verduijn","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: Can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/hmg\/ddv454","article-title":"A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration.","volume":"25","author":"De Vries","year":"2016","journal-title":"Hum Mol Genet"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood-2018-05-849240","article-title":"A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.","volume":"133","author":"De Vries","year":"2019","journal-title":"Blood"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/blood-2012-06-436188","article-title":"Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.","volume":"120","author":"Huang","year":"2012","journal-title":"Blood"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCULATIONAHA.118.034532","article-title":"Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels.","volume":"139","author":"Sabater-Lleal","year":"2019","journal-title":"Circulation"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1161\/CIRCULATIONAHA.110.009480","article-title":"Genetic predictors of fibrin D-dimer levels in healthy adults.","volume":"123","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1182\/blood-2010-05-283739","article-title":"Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study.","volume":"116","author":"Tang","year":"2010","journal-title":"Blood"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajhg.2012.05.009","article-title":"Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease.","volume":"91","author":"Tang","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/ng.3434","article-title":"Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus.","volume":"47","author":"Bentham","year":"2015","journal-title":"Nat Genet"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery.","volume":"506","author":"Okada","year":"2014","journal-title":"Nature"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.","volume":"365","year":"2019","journal-title":"Science"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/gepi.22295","article-title":"A comparison of robust Mendelian randomization methods using summary data.","volume":"44","author":"Slob","year":"2020","journal-title":"Genet Epidemiol"},{"key":"R30-20260911","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/bioinformatics\/btu779","article-title":"SNiPA:an interactive, genetic variant-centered annotation browser.","volume":"31","author":"Arnold","year":"2015","journal-title":"Bioinformatics"},{"key":"R31-20260911","doi-asserted-by":"crossref","first-page":"1167346","DOI":"10.3389\/fcvm.2023.1167346","article-title":"Causality of gut microbiome and hypertension: a bidirectional mendelian randomization study.","volume":"10","author":"Li","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R32-20260911","doi-asserted-by":"crossref","first-page":"780133","DOI":"10.3389\/fendo.2022.780133","article-title":"Genetically predicted causality of 28 gut microbiome families and type 2 diabetes mellitus risk.","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Endocrinol"},{"key":"R33-20260911","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.1","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023.","volume":"4","author":"Burgess","year":"2019","journal-title":"Wellcome Open Res"},{"issue":"3","key":"R34-20260911","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R35-20260911","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"elife"},{"key":"R36-20260911","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/10408347.2020.1793098","article-title":"Fibrinogen diagnostics in major hemorrhage.","volume":"52","author":"Bialkower","year":"2022","journal-title":"Crit Rev Anal Chem"},{"key":"R38-20260911","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2018-07-818211","article-title":"The multifaceted role of fibrinogen in tissue injury and inflammation.","volume":"133","author":"Luyendyk","year":"2019","journal-title":"Blood"},{"key":"R39-20260911","doi-asserted-by":"crossref","first-page":"100793","DOI":"10.1016\/j.blre.2020.100793","article-title":"Heterogeneity of congenital afibrinogenemia, from epidemiology to clinical consequences and management.","volume":"48","author":"Casini","year":"2021","journal-title":"Blood Rev"},{"key":"R40-20260911","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood.2019004781","article-title":"A Mendelian randomization of \u03b3\u2032 and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke.","volume":"136","author":"Maners","year":"2020","journal-title":"Blood"},{"key":"R41-20260911","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.3390\/ijms21249434","article-title":"Accelerated spatial fibrin growth and impaired contraction of blood clots in patients with rheumatoid arthritis.","volume":"21","author":"Peshkova","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R42-20260911","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s11064-023-03981-1","article-title":"Pathogenic role of fibrinogen in the neuropathology of multiple sclerosis: a tale of sorrows and fears.","volume":"48","author":"Alruwaili","year":"2023","journal-title":"Neurochem Res"},{"key":"R43-20260911","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1182\/blood-2018-01-769018","article-title":"von Willebrand factor regulation of blood vessel formation.","volume":"132","author":"Randi","year":"2018","journal-title":"Blood"},{"key":"R44-20260911","first-page":"EREP02","article-title":"The factor VIII\/von Willebrand factor complex: basic and clinical issues.","volume":"88","author":"Federici","year":"2003","journal-title":"Haematologica"},{"key":"R45-20260911","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.0801735105","article-title":"Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.","volume":"105","author":"Cao","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R46-20260911","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/ecco-jcc\/jjad198","article-title":"The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease.","volume":"18","author":"Schellenberg","year":"2023","journal-title":"J Crohns Colitis"},{"key":"R47-20260911","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1182\/blood.V96.13.4046","article-title":"Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets.","volume":"96","author":"Clemetson","year":"2000","journal-title":"Blood"},{"key":"R48-20260911","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0168-8278(02)00239-8","article-title":"Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease.","volume":"37","author":"Pihusch","year":"2002","journal-title":"J Hepatol"},{"key":"R49-20260911","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/s00403-023-02706-2","article-title":"Increased d-dimer and fibrin degradation product levels as potential indicators for evaluating infection-related acute urticaria: a case\u2013case\u2013control study.","volume":"315","author":"Zhang","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R50-20260911","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/ijms20071762","article-title":"The cardioprotective signaling activity of activated protein C in heart failure and ischemic heart diseases.","volume":"20","author":"Ren","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R51-20260911","doi-asserted-by":"crossref","first-page":"1251017","DOI":"10.3389\/fnins.2023.1251017","article-title":"Activated protein C in epilepsy pathophysiology.","volume":"17","author":"Zoungrana","year":"2023","journal-title":"Front Neurosci"},{"key":"R52-20260911","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fnins.2020.00333","article-title":"Activated protein C attenuates experimental autoimmune encephalomyelitis progression by enhancing vascular integrity and suppressing microglial activation.","volume":"14","author":"Kant","year":"2020","journal-title":"Front Neurosci"},{"key":"R53-20260911","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/ard.2005.041673","article-title":"Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment.","volume":"65","author":"Giannouli","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R54-20260911","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00296-013-2817-x","article-title":"An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus.","volume":"34","author":"Pretorius","year":"2014","journal-title":"Rheumatol Int"},{"key":"R55-20260911","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1001\/archinte.160.13.2042","article-title":"Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.","volume":"160","author":"Wahl","year":"2000","journal-title":"Arch Intern Med"},{"key":"R56-20260911","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean platelet volume: a link between thrombosis and inflammation?","volume":"17","author":"Yuri Gasparyan","year":"2011","journal-title":"Curr Pharm Des"},{"key":"R57-20260911","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/art.21172","article-title":"Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.","volume":"53","author":"Afeltra","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R58-20260911","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/01.ASN.0000015617.39974.FB","article-title":"Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells.","volume":"13","author":"Reisdorff","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R59-20260911","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"R60-20260911","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1038\/sj.onc.1201111","article-title":"Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors.","volume":"14","author":"Westermarck","year":"1997","journal-title":"Oncogene"},{"key":"R61-20260911","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2133.2011.10324.x","article-title":"Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo.","volume":"165","author":"Kumar","year":"2011","journal-title":"Br J Dermatol"},{"key":"R62-20260911","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/ijms25010370","article-title":"Involvement of PAR-2 in the induction of cell-specific matrix metalloproteinase-2 by activated protein C in cutaneous wound healing.","volume":"25","author":"Julovi","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:05:02Z","timestamp":1789142702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000040893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,27]]},"references-count":61,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040893","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,27]]}}}